Skip to main content

Tectonic Therapeutic, Inc.

corporate_fare Company Profile

Tectonic Therapeutic, Inc.

TECX·NASDAQ·Life Sciences·CIK 0001681087

Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies that modulate G-protein coupled receptors ("GPCRs"). The company has developed a proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery) to address challenges in discovering biologics that can modulate GPCRs. This platform aims to enable the discovery and development of GPCR-targeted biologic medicines designed to modify the course of disease. Tectonic focuses on areas with significant unmet medical needs, particularly where therapeutic options are limited or absent, and where new medicines could improve patients' quality of life. GPCRs are receptor molecules on cell surfaces that act as sensors for extracellular stimuli, facilitating communication between cells and their environment. These molecules regulate various aspects of human biology, including blood pressure, glucose metabolism, neuronal signaling, and immune surveillance. Over 800 human genes encode GPCRs, highlighting their role in physiological control. More than 30% of all approved drugs target GPCRs, though most are small molecules and target a limited number of GPCR subfamilies. Tectonic believes biologics could offer advantages over small molecules for this class of targets in many situations.

Tectonic Therapeutic, Inc. (NASDAQ:TECX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for TECX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for TECX spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Tectonic 10-Q: $21.3M Q3 Loss, $234.7M Cash, $22.3M Net ATM Proceeds
  • Tectonic Posts Q3 Loss of $21.3M, Cash Runway Into Q1 2029, APEX Data Due January 2027
  • Tectonic's TX2100 Shows Favorable Phase 1a Safety, Wins FDA Fast Track for HHT
  • Cronos Network Restarts After $74M Tectonic Exploit; Only $6M Bridged Out
  • Cronos Halts After $75M Tectonic Exploit via TONIC Price Manipulation

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$74.15M
Diluted EPS
-$4.05
Op. Cash Flow
-$60.08M
Free Cash Flow
-$60.29M
Operating Income
-$84.04M
Cash & Equivalents
$253.8M
Debt / Equity
0.00×
Shares Outstanding
18.74M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-076793

Short Interest & Short Volume

13.66 days to cover

FINRA reported short interest of 2,375,596 shares in TECX as of the October 30, 2026 settlement, a 6.8% increase from the prior period — about 13.7 days to cover at its recent average daily volume. On November 20, 2026, 70.6% of TECX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,375,596 shares as of October 30, 2026
Change vs prior period▲ 6.8%
Days to cover13.66 at avg daily volume of 173,921
Daily short volume (FINRA facilities)70.6% of 127,327 shares on November 20, 2026
5-day average short volume64.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$22.44 +6.65% today
52-week range · as of 2026-11-05 $15.52 – $39.53
Market cap
$413.52M
Volume
268.8K (1.5× avg)
3-mo avg 180.3K
Live data · 2026-11-21 05:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TECX - Latest Insights

TECX
Nov 05, 2026, 4:39 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.42
Real-time Price: $22.44 info
Change: +$3.02 (+16%) info
Market Cap: $413.523M info
TECX
Nov 05, 2026, 4:28 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.42
Real-time Price: $22.44 info
Change: +$3.02 (+16%) info
Market Cap: $413.523M info
TECX
Sep 29, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Updated Sep 29, 5:23 PM ET — Tectonic announced favorable Phase 1a safety, tolerability and PK results for TX2100, FDA Fast Track designation, and IND clearance for the…
Price at Filing: $23.51
Real-time Price: $22.44 info
Change: -$1.07 (-5%) info
Market Cap: $413.523M info
TECX
Aug 31, 2026, 10:29 AM EDT
Source: Coinpedia
Importance Score:
7
Price at Filing: $30.88
Real-time Price: $22.44 info
Change: -$8.44 (-27%) info
Market Cap: $413.523M info
TECX
Aug 30, 2026, 2:40 PM EDT
Source: The Block
Importance Score:
9
Price at Filing: $35.62
Real-time Price: $22.44 info
Change: -$13.18 (-37%) info
Market Cap: $413.523M info
TECX
Aug 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.22
Real-time Price: $22.44 info
Change: -$7.78 (-26%) info
Market Cap: $413.523M info
TECX
Jun 10, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.05
Real-time Price: $22.44 info
Change: -$5.61 (-20%) info
Market Cap: $413.523M info
TECX
Jun 10, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $28.05
Real-time Price: $22.44 info
Change: -$5.61 (-20%) info
Market Cap: $413.523M info
TECX
May 07, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $26.62
Real-time Price: $22.44 info
Change: -$4.18 (-16%) info
Market Cap: $413.523M info
TECX
May 07, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.62
Real-time Price: $22.44 info
Change: -$4.18 (-16%) info
Market Cap: $413.523M info
TECX
May 07, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $26.62
Real-time Price: $22.44 info
Change: -$4.18 (-16%) info
Market Cap: $413.523M info
TECX
Apr 24, 2026, 4:39 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $28.54
Real-time Price: $22.44 info
Change: -$6.10 (-21%) info
Market Cap: $413.523M info
TECX
Apr 23, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.44
Real-time Price: $22.44 info
Change: -$6.00 (-21%) info
Market Cap: $413.523M info
TECX
Feb 26, 2026, 4:21 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $23.79
Real-time Price: $22.44 info
Change: -$1.35 (-6%) info
Market Cap: $413.523M info
TECX
Feb 24, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.35
Real-time Price: $22.44 info
Change: +$1.09 (+5%) info
Market Cap: $413.523M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets